Brookfield Corp (BN)vsApplied DNA Sciences, Inc. (BNBX)
BN
Brookfield Corp
$42.37
-1.60%
FINANCIAL SERVICES · Cap: $93.39B
BNBX
Applied DNA Sciences, Inc.
$0.13
+48.11%
FINANCIAL SERVICES · Cap: $2.72M
Smart Verdict
WallStSmart Research — data-driven comparison
Brookfield Corp generates 3779244% more annual revenue ($79.11B vs $2.09M). BN leads profitability with a 1.7% profit margin vs 0.0%. BNBX appears more attractively valued with a PEG of 1.27. BN earns a higher WallStSmart Score of 63/100 (C+).
BN
Buy63
out of 100
Grade: C+
BNBX
Hold48
out of 100
Grade: D+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 158.8% YoY
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 28.9%
Reasonable price relative to book value
Revenue surging 34.3% year-over-year
Areas to Watch
ROE of 2.8% — below average capital efficiency
1.7% margin — thin
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BN
The strongest argument for BN centers on EPS Growth, Market Cap, Price/Book. PEG of 1.27 suggests the stock is reasonably priced for its growth.
Bull Case : BNBX
The strongest argument for BNBX centers on Price/Book, Revenue Growth. Revenue growth of 34.3% demonstrates continued momentum. PEG of 1.27 suggests the stock is reasonably priced for its growth.
Bear Case : BN
The primary concerns for BN are Return on Equity, Profit Margin, P/E Ratio. A P/E of 82.0x leaves little room for execution misses. Debt-to-equity of 5.72 is elevated, increasing financial risk.
Bear Case : BNBX
The primary concerns for BNBX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
BN profiles as a value stock while BNBX is a hypergrowth play — different risk/reward profiles.
BN carries more volatility with a beta of 1.84 — expect wider price swings.
BNBX is growing revenue faster at 34.3% — sustainability is the question.
BNBX generates stronger free cash flow (-2M), providing more financial flexibility.
Bottom Line
BN scores higher overall (63/100 vs 48/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Brookfield Corp
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Brookfield Corporation is an alternative asset manager and REIT/Real Estate Investment Manager firm focuses on real estate, renewable power, infrastructure and venture capital and private equity assets. The company is headquartered in Toronto, Canada with additional offices across Northern America; South America; Europe; Middle East and Asia.
Applied DNA Sciences, Inc.
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company is headquartered in Stony Brook, New York.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?